GlassScriptPhysician profile
John M Robinson
NPI 1699900191
$1,041.30
in general payments reported to CMS, 2019-2025
13 companies · $34.98 in 2025
The $34.98 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2023: $129 · 2024: $305 · 2025: $34.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $340.95 | 2019 | |
| Merck Sharp & Dohme LLC | $334.96 | 2019-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $167.32 | 2019-2024 | Calquence |
| Foundation Medicine, INC. | $38.02 | 2023 | Foundationone Cdx, Foundationone Liquid Cdx |
| Daiichi Sankyo INC. | $27.40 | 2024 | Enhertu |
| Mimedx Group, INC. | $20.35 | 2024 | |
| Sobi, INC | $17.38 | 2024 | |
| Masimo Corporation | $17.34 | 2023 | Patient Safetynet System, Set and Rainbow Set |
| Genmab U.S., INC. | $17.16 | 2025 | Tivdak |
| Tersera Therapeutics LLC | $16.51 | 2024 | Zoladex |
| Alexion Pharmaceuticals, INC. | $16.10 | 2023 | Ultomiris |
| Medtronic, INC. | $14.40 | 2024 | Truclear |
| Eisai INC. | $13.41 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.